Genomic analysis of individual patients is now affordable and therapies targeted to specific molecular aberrations are being tested in clinical trials. However, even highly-specialized physicians at leading academic centers are not equipped to apply genomic information available in publically available sources to clinical- decision-making concerning individual patients. Our central hypothesis is that we can develop informatics tools to support personalized cancer treatment as "standard of care" rather than "one off" exceptions. We will: 1) implement a bioinformatics pipeline for processing molecular data into actionable profiles, 2) create and maintain a database of therapeutic implications of common genomic aberrations using automated processing of publically-available sources and 3) develop tools to summarize and present patient-specific advice to clinicians. These tools will be based on existing technologies and publicly available data sources. Once tested, we will make these tools available via appropriate open source license.
Genomic analysis of individual patients is now affordable and therapies targeted to specific molecular aberrations are being tested in clinical trials. In this project, we will develop informatics tools to support personalized cancer treatment as standard of care rather than one off exception.
|Yu, Zhiguo; Bernstam, Elmer; Cohen, Trevor et al. (2016) Improving the utility of MeSHÂ® terms using the TopicalMeSH representation. J Biomed Inform 61:77-86|
|Roszik, Jason; Haydu, Lauren E; Hess, Kenneth R et al. (2016) Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set. BMC Med 14:168|
|Rogith, Deevakar; Yusuf, Rafeek A; Hovick, Shelley R et al. (2016) Patient knowledge and information-seeking about personalized cancer therapy. Int J Med Inform 88:52-7|
|Meric-Bernstam, Funda; Johnson, Amber; Holla, Vijaykumar et al. (2015) A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst 107:|
|Meric-Bernstam, Funda; Brusco, Lauren; Shaw, Kenna et al. (2015) Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials. J Clin Oncol 33:2753-62|
|Chen, Ken; Meric-Bernstam, Funda; Zhao, Hao et al. (2015) Clinical actionability enhanced through deep targeted sequencing of solid tumors. Clin Chem 61:544-53|
|Chen, Guocai; Zhao, Jieyi; Cohen, Trevor et al. (2015) Using Ontology Fingerprints to disambiguate gene name entities in the biomedical literature. Database (Oxford) 2015:bav034|
|Joffe, Erel; Pettigrew, Emily J; Herskovic, Jorge R et al. (2015) Expert guided natural language processing using one-class classification. J Am Med Inform Assoc 22:962-6|
|Roy-Chowdhuri, Sinchita; de Melo Gagliato, Debora; Routbort, Mark J et al. (2015) Multigene clinical mutational profiling of breast carcinoma using next-generation sequencing. Am J Clin Pathol 144:713-21|
|Boland, Genevieve M; Piha-Paul, Sarina A; Subbiah, Vivek et al. (2015) Clinical next generation sequencing to identify actionable aberrations in a phase I program. Oncotarget 6:20099-110|
Showing the most recent 10 out of 17 publications